Le Lézard
Classified in: Health
Subject: SVY

Burnout Lower for Family Physicians Able to Address Patients' Social Needs


LEXINGTON, Ken., Jan. 17, 2019 /PRNewswire-PRWeb/ -- Data analyzed data from the American Board of Family Medicine's (ABFM) 2016 Family Medicine Certification practice demographic questionnaire found family physicians with a high perception of their clinic's capacity to meet patients' social needs were less likely to report burnout.

The study, conducted by the University of California, San Francisco School of Medicine and the ABFM, investigated the association between clinic capacity to address social needs and burnout among family physicians. Twenty-seven percent of respondents reported symptoms of burn out, similar to another recent study. Burnout risk factors reported include electronic health record (EHR) burden, work stress, poor team efficiency, and poor or misaligned clinical leadership.

Burnout refers to the psychological exhaustion resulting from long-term stress, and it puts physicians at risk for poor mental health, decreased productivity, and abandonment of career medicine.

The American Board of Family Medicine has developed the Population Health Assessment Engine (PHATE) to help its Diplomates better understand their patients' social risks and to support addressing their social needs (http://primeregistry.org/phate/).

The complete Article Physician Burnout and Higher Clinic Capacity to Address Patients' Social Needs may be found at https://www.jabfm.org/content/32/1/69?etoc=

Inquiries and correspondence should be addressed to Lars E. Peterson, MD, PhD, American Board of Family Medicine, 1648 McGrathiana Parkway, Suite 550, Lexington, KY 40511-1247; email: lpeterson(at)theabfm(dot)org.

 

SOURCE American Board of Family Medicine


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: